Target intelligence / Profile preview

Plakophilin-1 (PKP1)

Target
PKP1
Molecular classification
Other (member of the arm-repeat/armadillo-repeat protein family, desmosomal plaque protein)
01

Overview

Plakophilin-1 is an armadillo repeat-containing protein localized to both desmosomes and the nucleus, encoded by the PKP1 gene. It is essential for the structural integrity of desmosomal plaques, mediating cell-cell adhesion by linking cadherins (e.g., desmoglein 1) to intermediate filaments (e.g., keratins). Plakophilin-1 plays a pivotal role in desmosome assembly, keratinocyte differentiation, and epidermal morphogenesis. Mutations in PKP1 disrupt desmosome structure, leading to skin fragility syndromes such as ectodermal dysplasia/skin fragility syndrome[1][3][4]. Plakophilin-1 is not a conventional therapeutic target like a receptor or enzyme; its disease associations primarily reflect loss-of-function genetics rather than druggable pharmacology. It is involved in regulation of the actin cytoskeleton and also in control of protein translation and cell proliferation[4][6].

Other names
Band 6 proteinB6PEctodermal dysplasia/skin fragility syndrome proteinEDSFSplakophilin-1PKP1band 6 protein
02

Biological functions

Cell adhesionDesmosome assemblyKeratinocyte differentiationRegulation of cytoskeletal dynamicsRegulation of translationRegulation of cell proliferationRecruitment and stabilization of desmosomal proteinsRegulation of actin filament organization
03

Disease associations

Ectodermal dysplasia/skin fragility syndromeEpidermolysis bullosa simplex (generalized, intermediate or severe, autosomal recessive)Other skin fragility disorders
04

Biomarkers

Skin fragility (mutation as a diagnostic marker for ectodermal dysplasia/skin fragility syndrome)

Beyond the preview

Go deeper on Plakophilin-1 (PKP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plakophilin-1 (PKP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call